These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 24365616

  • 1. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J, Tanaka K, Czapla J, Vanderhasselt T, Kayaert P, Scott B, Sutherland G, Van Camp G.
    Int J Cardiol; 2014 Feb 01; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract] [Full Text] [Related]

  • 2. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
    Nishimura RA, Ommen SR.
    JAMA; 2007 Jul 25; 298(4):452-4. PubMed ID: 17652299
    [No Abstract] [Full Text] [Related]

  • 3. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP.
    J Cardiovasc Electrophysiol; 2010 Sep 25; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract] [Full Text] [Related]

  • 4. [Sudden death and ventricular fibrillation of possible ischemic origin in a boy with hypertrophic myocardiopathy].
    Gutiérrez Díez A, Tamariz-Martel Moreno A, Baño Rodrigo A, Serrano González A.
    Rev Esp Cardiol; 2000 Feb 25; 53(2):290-3. PubMed ID: 10734761
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P.
    N Engl J Med; 2000 Feb 10; 342(6):365-73. PubMed ID: 10666426
    [Abstract] [Full Text] [Related]

  • 6. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH, Van Gelder IC.
    Europace; 2014 Jul 10; 16(7):1032. PubMed ID: 24792457
    [No Abstract] [Full Text] [Related]

  • 7. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE, Bellenger N, Spurrell P.
    Heart; 2009 Nov 10; 95(22):1843. PubMed ID: 19875370
    [No Abstract] [Full Text] [Related]

  • 8. Ambulatory monitoring of aborted sudden cardiac death related to hypertrophic cardiomyopathy.
    Vaglio JC, Sorajja P, Gersh BJ.
    Nat Clin Pract Cardiovasc Med; 2005 Dec 10; 2(12):659-62; quiz following 662. PubMed ID: 16306922
    [Abstract] [Full Text] [Related]

  • 9. Unusual causes of sudden cardiac death due to ventricular tachyarrhythmias.
    Gillis AM, Hamilton RM, LeFeuvre CA.
    Can J Cardiol; 2000 Jun 10; 16 Suppl C():34C-40C. PubMed ID: 10887277
    [No Abstract] [Full Text] [Related]

  • 10. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H, Chinushi M, Iijima K, Sanada A, Izumi D, Hosaka Y, Aizawa Y.
    J Cardiovasc Electrophysiol; 2010 Sep 10; 21(9):991-9. PubMed ID: 20487113
    [Abstract] [Full Text] [Related]

  • 11. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
    Talard P, Lévy S, Bonal J, Paganelli F, Bouchiat C, Cellarier G, Dussarat GV.
    Pacing Clin Electrophysiol; 1996 Aug 10; 19(8):1264-7. PubMed ID: 8865227
    [Abstract] [Full Text] [Related]

  • 12. Aborted sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ, Casey SA, Almquist AK.
    J Cardiovasc Electrophysiol; 1999 Feb 10; 10(2):263. PubMed ID: 10090231
    [No Abstract] [Full Text] [Related]

  • 13. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ, Estes NA, Maron MS, Almquist AK, Link MS, Udelson JE.
    Circulation; 2003 Jun 17; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract] [Full Text] [Related]

  • 14. Aborted sudden cardiac death in a child with left ventricular non-compaction.
    Ergul Y, Nisli K, Bilge AK, Dindar A.
    Pediatr Int; 2013 Jun 17; 55(3):388-91. PubMed ID: 23782373
    [Abstract] [Full Text] [Related]

  • 15. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.
    J Am Coll Cardiol; 2013 Apr 09; 61(14):1527-35. PubMed ID: 23500286
    [Abstract] [Full Text] [Related]

  • 16. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease.
    Waller JR, Salmon AP, Roberts PR.
    Europace; 2015 Jan 09; 17(1):77. PubMed ID: 25414482
    [No Abstract] [Full Text] [Related]

  • 17. The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.
    Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ.
    Heart; 2012 Apr 09; 98(8):631-6. PubMed ID: 22505462
    [Abstract] [Full Text] [Related]

  • 18. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I, Lekanne dit Deprez RH, van Langen IM, Wilde AA.
    Heart Rhythm; 2009 Sep 09; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C, Elliott PM.
    Heart; 2014 Feb 09; 100(3):254-60. PubMed ID: 23574968
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.